Moderna wants to give FDA ‘flexibility’ in deciding eligibility for 4th Covid shot, CEO says

Moderna wanted to provide U.S. regulators “flexibility” in determining eligibility for a fourth Covid vaccine dose, CEO Stephane Bancel told CNBC.
The drugmaker asked the FDA to clear the additional shot for all Americans ages 18 and up.
“You have people that are younger adults that have comorbidity factors, and they might need sooner fourth dose to protect them,” Bancel said.